[Immunological studies and immunotherapeutic possibilities in inoperable bronchogenic carcinoma (author's transl)]
[Article in
German]
- PMID: 461311
Item in Clipboard
[Immunological studies and immunotherapeutic possibilities in inoperable bronchogenic carcinoma (author's transl)]
[Article in
German]
Prax Klin Pneumol.
1979 Apr.
Abstract
By establishing an immune profile combined with detailed clinical observation an attempt was made to assess the value of various therapeutic measures, especially immunological methods, in the treatment of inoperable bronchogenic carcinoma. The results indicated that in advanced cases specific immunological measures or stimulation of the immune mechanism only play a supportive role. Toxic side-effects or tumour enhancement were absent.
Similar articles
-
[Immunology and immunotherapy of lung cancer--experimental and clinical investigations (author's transl)].Wien Klin Wochenschr Suppl. 1978;90:1-28. Wien Klin Wochenschr Suppl. 1978. PMID: 362733 Review. German. No abstract available.
-
Tumour-associated antigens in lung cancer: the possibility for a serologic assay.Can Med Assoc J. 1980 May 10;122(9):1020-3. Can Med Assoc J. 1980. PMID: 7370881 Free PMC article.
-
Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).Cancer Treat Rep. 1985 Mar;69(3):251-8. Cancer Treat Rep. 1985. PMID: 2983892
-
[Immunological monitoring of patients operated on for epidermoid bronchogenic carcinoma].Chir Ital. 1981 Feb;33(1):47-59. Chir Ital. 1981. PMID: 7261218 Italian.
-
Soluble proteins of human bronchogenic carcinomas.Mayo Clin Proc. 1976 Jan;51(1):19-27. Mayo Clin Proc. 1976. PMID: 765635 Review.